Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death

Cancer Research

Volumn 57, Issue 1, 1997, Pages 130-135

  Blagosklonny, Mikhail V ^a   Giannakakou, Paraskevi ^b   El Deiry, Wafik S ^a   Kingston, David G I ^c   Higgs, Paul I ^c   Neckers, Len ^b   Fojo, Tito ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; CHELERYTHRINE; CISPLATIN; COLCHICINE; CYCLOHEXIMIDE; DACTINOMYCIN; DAUNORUBICIN; DOXORUBICIN; EPOTHILONE A; EPOTHILONE B; FLUOROURACIL; JASPAMIDE; MAYTANSINE; MELPHALAN; METHOTREXATE; MITOMYCIN C; PACLITAXEL; PHORBOL 13 ACETATE 12 MYRISTATE; PODOPHYLLOTOXIN; PROTEIN BCL 2; RAF PROTEIN; UNCLASSIFIED DRUG; VANADATE SODIUM; VINBLASTINE; VINCRISTINE; WORTMANNIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RNA SYNTHESIS;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG RESISTANCE; ENZYME ACTIVATION; FEMALE; HUMANS; MICROTUBULES; PACLITAXEL; PHOSPHORYLATION; POLYMERS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-RAF; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0031036307     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Mitra, G., Weber, M., and Stacey, D. Multiple pathways for activation of MAP kinases. Cell. Mol. Biol. Res., 39: 517-523, 1993.
2. Troppmair, J., Bruder, J. T., Munoz, H., Lloyd, P. A., Kyriakis, J., Banerjee, P., Avruch, J., and Rapp, U. R. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J. Biol. Chem., 269: 7030-7035, 1994.
3. Daum, G., Eisenmann-Tappe, I., Fries, H. W., Troppmair, J., and Rapp, U. R. The ins and outs of Raf kinases. Trends Biochem. Sci., 19: 474-480, 1994.
4. Wang, H-G., Miyashita, T., Takayama, S., Sato, T., Torigoe, S., Krajewski, S., Tanaka, S., Hovey, L., III, Troppmair, J., Rapp, U. R., and Reed, J. C. Apoptosis regulation by interaction of bcl-2 protein and Raf-1 kinase. Oncogene, 9: 2751-2756, 1994.
5. Waf1 and p53 requires c-raf-1. Cancer Res., 55: 4623-4626, 1995.
6. Blagosklonny, M. V., Schulte, T. W., Nguyen, P., Trepel, J., and Neckers, L. Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res., 56: 1851-1854, 1996.
7. Horwitz, S. B. Mechanism of action of Taxol. Trends Pharamacol. Sci., 13: 134-136, 1992.
8. Kumar, N. Taxol induced polymerization of purified tubulin: mechanism of action. J. Biol. Chem., 256: 10435-10441, 1981.
9. Manfredi, J. J., Parness, J., and Horwitz, S. B. Taxol binds to cellular microtubules. J. Biol. Chem., 94: 688-696, 1982.
10. Schiff, P. B., and Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980.
11. Rowinsky, E. K., Donehower, R. C., Jones, R. J., and Tucker, R. W. Microtubule changes and cytotoxicity in leukemic cell lines treated with Taxol. Cancer Res., 48: 4093-4100, 1988.
12. Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D., and Lazarides, E. Taxol-induced mitotic block triggers rapid onset of a p53 independent apoptotic pathway. Mol. Med., 1: 506-526, 1995.
13. Kung, A. L., Zetterberg, A., Sherwood, A. W., and Schimke, R. T. Cytotoxic effects of cell cycle specific agents: a result of cell cycle perturbation. Cancer Res., 50: 7307-7314, 1990.
14. Donaldson, K. L., Goolsby, G., Kiener, P. A., and Wahl, A. F. Activation of p34cdc coincident with Taxol-induced apoptosis. Cell Growth & Differ., 5: 1041-1050, 1994.
15. Tsujimoto, Y., and Croce, C. M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA, 83: 5214-5218, 1986.
16. Reed, J. C., Tsujimoto, Y., Alpers, J. D., Croce, C. M., and Nowell, P. C. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science (Washington DC), 236: 1295-1299, 1987.
17. Reed, J. C. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol., 7: 541-546, 1995.
18. Korsmeyer, S. J. Regulators of cell death. Trends Genet., 11: 101-105, 1995.
19. Haldar, S., Jena, N., and Croce, C. M. Inactivation of bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92: 4507-4511, 1995.
20. Haldar, S., Chintapalli, J., and Croce, C. M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56: 1253-1255, 1996.
21. Chaudhary, A. G., Gharpure, M. M., Rimoldi, J. M., Chordia, M. D., Gunatilaka, A. A. L., Kingston, D. G. I., Grover, S., Lin, C. M., and Hamel, E. Unexpectedly facile hydrolysis of the 2-benzoate group of Taxol and synthesis of analogs with increased activities. J. Am. Chem. Soc., 116: 4097-4098, 1994.
22. Giannakakou, P., Sackett, D., Kang, Y-K., Fojo, A. T., and Poruchynsky, M. Tubulin from paclitaxel resistant human ovarian carcinoma cell lines demonstrates altered response to drug in vivo and in vitro. Proc. Am. Assoc. Cancer Res., 37: 320, 1996.
23. Lee, J. S., Paull, K., Alvarez, M., Hose, C., Monks, A., Grever, M., Fojo, A. T., and Bates, S. E. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute Drug Screen. Mol. Pharmacol., 46: 627-638, 1994.
24. Minotti, A. M., Barlow, S. B., and Cabral, F. Resistance to antimitotic drugs in Chinese hamster ovary cells correlates with changes in the level of polymerized tubulin. J. Cell. Biochem., 266: 3987-3994, 1991.
25. Darzynkiewicz, Z., Li, X., and Gong, J. Assays of cell viability: discrimination of cells dying by apoptosis. Methods Cell Biol., 41: 15-38, 1994.
26. Meijer, L., Azzi, L., and Wang, J. Y. Cyclin B. Targets p34cdc2 for tyrosine phosphorylation. EMBO J., 10: 1545-1554, 1996.
27. Bubb, M. R., Senderowicz, A. M. J., Sausville, E. A., Duncan, K. L. K., and Korn, E. D. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J. Biol. Chem., 269: 14869-14871, 1994.
28. Bollag, D. M., McQueney, P. A., Zhu, J., Hensens, O., Koupal, L., Liesch, J., Goetz, M., Lazarides, E., and Woods, C. M. Epothilones, a new class of microtubule-stabilizing agents with a Taxol-like mechanism of action. Cancer Res., 55: 2325-2333, 1995.
29. Sackett, D.I. Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents. Biochemistry, 34: 7010-7019, 1995.
30. Ding, A. H., Poteu, F., Sanchez, E., and Nathan, C. F. Shared actions of endotoxin and Taxol on TNFα receptors and TNFα release. Science (Washington DC), 248: 370-375, 1990.
31. Manthey, C. L., Brandes, M. E., Perera, P. Y., and Vogel, S. N. Taxol Increases steady state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in mutine macrophages. J. Immunol., 149: 2459-2464, 1992.
32. Liu, Y., Bhalla, K., Hill, C., and Priest, D. G. Evidence for involvement of lyrosine phosphorylation in Taxol-induced apoptosis in a human ovarian tumor cell line. Biochem. Pharmacol., 48: 1265-1272, 1994.
33. Lu, Q. L., Hanby, A. M., Nasser Hajibagheri, M. A., Gschmeissner, S. E., Lu, P. J., Taylor-Papadimitriou, J., Krajewski, S., Reed, J. C., and Wright, N. A. bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J. Cell Sci., 107: 363-371, 1994.
34. Willingham, M. C., and Bhalla, K. J. Transient mitotic phase localization of bcl-2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis. Histochem. Cytochem., 42: 441-450, 1994.
35. Bhalla, K., Ibrado, A. M., Tourkina, E., Tang, C., Maloney, M. E., and Huang, Y. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia (Baltimore), 7: 563-568, 1993.
36. May, W. S., Tyler, P. G., Ito, T., Armstrong, D. K., Qatsha, K. A., and Davidson, N. E. Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2a in association with suppression of apoptosis. J. Biol. Chem., 269: 26865-26870, 1994.
37. Cross, S. M., Sanchez, C, A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., and Reid, B. J. A p-53 dependent mouse spindle checkpoint. Science (Washington DC), 267: 1353-1356, 1995.
38. Wahl, A. F., Donaldson, K. L., Fairchild, C., Lee, F. Y., Foster, S. A., Demers, G. W., and Galloway, D. A. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat. Med., 2: 72-79, 1996.
39. Tishler, R. B., Lamppu, D. M., Park, S., and Price, B. D. Microtubule-active drugs, Taxol, vinblastine and nocodazole increase the levels of transcriptionally active p53. Cancer Res., 55: 6021-6025, 1995.
40. Blagosklonny, M. V., Toretsky, J., and Neckers, L. M. Geldanamycin selectively destabilizes and conformationally alters mutated p53. Oncogene, 11: 933-939, 1995.